shortagewatch

Home / Digestive tract and metabolism / Ondansetron

ATC A04AA01 · Antiemetics and Antinauseants

Ondansetron shortage

As of 31 Oct 2026, Ondansetron has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 13 products.

Countries3/5
Products13packs or presentations
Short since12 Jul 20233.3 years ago
Earliest return2 Nov 2026company estimate
No return date10products
Main reasonNot stated
GermanyNo reported shortageItaly7 packs shortSpain5 packs shortAustria1 pack shortBelgiumNo reported shortage

Timeline

ItalySpainAustria
202420252026ONDANSETRONE MYLAN GENERICS ITALIAONDANSETRONE MYLAN GENERICS ITALIAONDANSETRONE MYLAN GENERICSONDANSETRONE MYLAN GENERICSONDANSETRONE MYLAN GENERICSONDANSETRONE MYLAN GENERICSONDANSETRONE ACCORD HEALTHCAREONDANSETRONE ACCORD HEALTHCAREONDANSETRON EGONDANSETRON EGONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 4 mlONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 2 mlZOFRAN ZYDIS 4 mg LIOFILIZADO ORAL , 10 liofZOFRAN ZYDIS 4 mg LIOFILIZADO ORAL , 10 liofilizadosZOFRAN 4 mg SOLUCION INYECTABLE,10 ampollas ZOFRAN 4 mg SOLUCION INYECTABLE,10 ampollas de 2 mlZOFRAN ZYDIS 8 mg LIOFILIZADO ORAL , 10 liofZOFRAN ZYDIS 8 mg LIOFILIZADO ORAL , 10 liofilizadosOndansetron Accord 2 mg/ml Injektions- oder Ondansetron Accord 2 mg/ml Injektions- oder Infusionslösung, 5 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITONDANSETRONE MYLAN GENERICS ITALIAMYLAN S.P.A.1 Dec 2025not givenManufacturing problem
Problemi produttivi
ITONDANSETRONE MYLAN GENERICSMYLAN S.P.A.22 Jan 2026not givenIncreased demand
Elevata richiesta
ITONDANSETRONE MYLAN GENERICSMYLAN S.P.A.15 Apr 2026not givenIncreased demand
Elevata richiesta
ITONDANSETRONE ACCORD HEALTHCAREACCORD HEALTHCARE, S.L.U.8 May 2026not givenIncreased demand
Elevata richiesta
ITONDANSETRON EGEG S.P.A.22 Jul 2026not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITONDANSETRON EG announcedEG S.P.A.1 Dec 2026not givenManufacturing problem
Problemi produttivi
ITONDANSETRONE TEVA announcedTEVA ITALIA S.R.L.4 Dec 202631 Dec 2026Increased demand
Elevata richiesta (carenza relativa solo al canale ospedaliero)
ESONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 4 mlLaboratorios Serra Pamies S.A.U.12 Jul 2023not givenNot stated
ESONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 2 mlLaboratorios Serra Pamies S.A.U.21 Nov 2023not givenNot stated
ESZOFRAN ZYDIS 4 mg LIOFILIZADO ORAL , 10 liofilizadosBexal Farmaceutica S.A.30 Aug 2026not givenNot stated
ESZOFRAN 4 mg SOLUCION INYECTABLE,10 ampollas de 2 mlBexal Farmaceutica S.A.10 Sep 2026not givenNot stated
ESZOFRAN ZYDIS 8 mg LIOFILIZADO ORAL , 10 liofilizadosBexal Farmaceutica S.A.7 Oct 20262 Nov 2026Not stated
ATOndansetron Accord 2 mg/ml Injektions- oder Infusionslösung, 5 StückAccord Healthcare B.V.12 Oct 202631 Dec 2026Manufacturing problem
Verzögerung bei der Herstellung

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Granisetron Palonosetron